Business Name: |
Runyan Thomas E MD |
Contact Person: |
Thomas Runyan |
Address: |
303 Harris Industrial Boulevard # 2, Vidalia, Georgia 30474 |
Phone Number: |
(912) 537-4414 |
Website Address: |
painmanagementphysician.net |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Hofmann Kurt P MD - Vidalia, GA 30474 South Georgia Allergy Clinic - Vidalia, GA 30474 Mcalpine Candace N MD - Vidalia, GA 30474 Shaw Nancy A MD - Vidalia, GA 30474 Osborne Timothy J MD - Vidalia, GA 30474 Harden Jr Charles M MD - Vidalia, GA 30474 Dates Craig A MD - Vidalia, GA 30474 Collins Lewis MD - Vidalia, GA 30474 Horton Timothy C MD - Vidalia, GA 30474 Kim David D MD - Vidalia, GA 30474 Boss-Cole Etta W MD - Vidalia, GA 30474 Machado Claudio D MD - Vidalia, GA 30474 Schoell John MD - Vidalia, GA 30474 Flexon Phillip MD - Vidalia, GA 30474 Horn Thomas W MD - Vidalia, GA 30474 Ghazi Bahair H MD - Vidalia, GA 30474 Atekha Courage MD - Vidalia, GA 30474 Palmer Don MD - Vidalia, GA 30474 Spence John V MD - Vidalia, GA 30474 Turner Marjorie P MD - Vidalia, GA 30474 |
The company Runyan Thomas E MD provides B2C services in the form of Doctors from its single location in Georgia.
1 to 4 employees work for Runyan Thomas E MD, and the business now earns $500.000 to $999.999 per annum.
Runyan Thomas E MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Runyan Thomas E MD, please call Thomas Runyan with the phone number (912) 537-4414 or visit its single location at 303 Harris Industrial Boulevard # 2 in Vidalia, Georgia 30474.
The location of the single location can also be found using the coordinates 32.20706,-82.37731.
Read more details about this business on the webpage painmanagementphysician.net or follow the company’s social media accounts, on Twitter and on Facebook.